The University of Texas Medical Branch at Galveston is in the unique position to have been awarded funding to launch 2 of the 10 National Institute of Allergy and Infectious Diseases-supported Centers for Research in Emerging Infectious Diseases (CREID). The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE-NEO) center (1 U01 AI151807-01) led by Dr. Nikos Vasilakis and the West African Center of Emerging Infectious Diseases (WAC-EID; 1 U01 AI151801-01) led by Dr. Scott Weaver will coordinate efforts with the other NIAID funded centers around the globe where emerging and re-emerging infectious disease outbreaks are likely to occur. Multidisciplinary teams of investigators will conduct pathogen/host/vector surveillance, study pathogen transmission, pathogenesis and immunologic responses in the host, and will develop reagents and diagnostic assays for improved detection for important emerging pathogens and their vectors.